Clinical trial
Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With…
NCT00393796 · University of Michigan Rogel Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00393796 |
|---|---|
| Title | Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma |
| Official title | Randomized Blinded Phase II Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Collaborators | Pfizer Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Other |
| Interventions | SUTENT, Placebo |
| Enrollment | 54 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2012 |
| First posted | Oct 30, 2006 |
| Last update posted | Nov 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: